EQUITY RESEARCH MEMO
Cristers
Generated 5/9/2026
Executive Summary
Conviction (model self-assessment)65/100
Cristers is a French pharmaceutical laboratory specializing in generic drugs and over-the-counter (OTC) products, uniquely owned by the community pharmacy cooperative La Coopérative WELCOOP. Founded in 1990 and headquartered in Lyon, the company supplies French pharmacies with a broad portfolio covering major therapeutic areas including cardiology, neurology, diabetology, and oncology. As a privately held entity, Cristers benefits from a stable ownership structure aligned with its pharmacy customer base, enabling long-term strategic focus on affordable medication access. Its position as a cooperative-owned generic player differentiates it from multinational competitors, fostering loyalty among independent pharmacies.
Upcoming Catalysts (preview)
- Q3 2026Launch of new generic drugs in high-demand therapeutic categories70% success
- Q4 2026Expansion of OTC product line to capture growing self-care market60% success
- Q1 2027Potential strategic partnership or acquisition to broaden portfolio50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)